Sign in to continue:

Saturday, March 7th, 2026

Ellington Financial Inc. 8-K Filing Details, Company Information, and Stock Listings (March 5, 2026)

Ellington Financial Inc. Announces Estimated Book Value Per Common Share as of January 31, 2026

Ellington Financial Inc. (NYSE: EFC) has issued a significant update for its investors, announcing the estimated book value per share of its common stock as of January 31, 2026. The announcement was made via a press release dated March 5, 2026, and is disclosed in an official Form 8-K filing.

Key Points from the Report

  • Estimated Book Value Per Common Share: The company estimates its book value per share of common stock to be \$13.31 as of January 31, 2026.
  • Dividend Impact: This estimate includes the effect of the previously announced monthly dividend of \$0.13 per share of common stock, which was paid on February 27, 2026, to holders of record as of January 30, 2026 (ex-dividend date was the same).
  • Regulatory Disclosure: The information is furnished in compliance with Regulation FD, ensuring all investors have timely and equal access to material information.

Details for Shareholders and Potential Price Sensitivity

  • Materiality and Forward-Looking Nature: The estimated book value per share is subject to change following the completion of the company’s month-end and quarter-end valuation procedures. The company explicitly warns that any such change could be material, and the estimate provided as of January 31, 2026, may not reflect results for the quarter ending March 31, 2026, or subsequent periods.
  • Forward-Looking Statements and Risks: The press release contains forward-looking statements, highlighting risks such as changes in interest rates, the market value of investments, market volatility, default and prepayment rates, and the company’s ability to maintain REIT status and regulatory exclusions. Such risks could significantly impact the company’s financial position and, consequently, share price.
  • No Obligation to Update Estimate: The company does not undertake any obligation to update or revise the estimated book value prior to the issuance of full financial statements.
  • Trading Information:

    • Common Stock: Trading symbol EFC on the NYSE.
    • Preferred Shares: Multiple series are also listed, including Series B (EFC PR B), Series C (EFC PR C), and Series D (EFC PRD), all trading on the NYSE.

About Ellington Financial

Ellington Financial invests in a diverse portfolio of financial assets, including residential and commercial mortgage loans and securities, reverse mortgage loans, mortgage servicing rights, consumer loans, asset-backed securities, CLOs, derivatives, and strategic debt and equity investments in loan origination companies. The company operates as a real estate investment trust (REIT) and is headquartered in Old Greenwich, Connecticut.

Important Notes for Investors

  • Price-Sensitive Information: The disclosure of an estimated book value per share is a material event that can impact investor sentiment and the share price, especially when compared to the current trading price.
  • Risk Factors: Investors should be aware that the estimated figure is preliminary and may change. Any significant future adjustment could move the share price, positively or negatively.
  • Forward-Looking Risks: As with any company making forward-looking statements, there are inherent uncertainties and risks that could affect actual results, and investors are encouraged to review the risk factors detailed in Ellington Financial’s latest SEC filings.

Summary Table

Security Title Trading Symbol Exchange
Common Stock Common Stock, \$0.001 par value per share EFC NYSE
Series B Preferred 6.250% Series B Fixed-Rate Reset Cumulative Redeemable Preferred Stock EFC PR B NYSE
Series C Preferred 8.625% Series C Fixed-Rate Reset Cumulative Redeemable Preferred Stock EFC PR C NYSE
Series D Preferred 7.00% Series D Cumulative Perpetual Redeemable Preferred Stock EFC PRD NYSE


Disclaimer: This article is a summary and interpretation of Ellington Financial Inc.’s Form 8-K and press release dated March 5, 2026, and is intended for informational purposes only. The information provided herein does not constitute investment advice. Investors should review all official company filings and consult with their financial advisors before making investment decisions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.

View Ellington Financial Inc. Historical chart here



Information Services Group (ISG) Reports Strong Q4 and Full-Year 2025 Financial Results, AI Maturity Index Acquisition, and 2026 Outlook

Information Services Group (ISG) 2025 Results: Key Investor Insights Information Services Group Announces Strong Q4 and Full-Year 2025 Results, Accelerates AI Strategy STAMFORD, Conn., March 5, 2026 – Information Services Group (ISG) (Nasdaq: III),...

Alpha Teknova, Inc. 2025 Annual Report: Business Overview, Strategy, and Key Risk Factors

Alpha Teknova, Inc. 2025 Annual Report – Detailed Investor Analysis Alpha Teknova, Inc. 2025 Annual Report: Key Highlights and Shareholder Considerations Overview Alpha Teknova, Inc. (“Teknova”), a leading provider of critical reagents for the...

Delcath Systems’ CHOPIN Phase 2 Trial Shows Improved Survival with Combined Hepatic Perfusion and Immunotherapy in Metastatic Uveal Melanoma (Published in The Lancet Oncology)

Delcath Systems Announces Landmark CHOPIN Trial Results in The Lancet Oncology Delcath Systems Announces Landmark CHOPIN Trial Results in The Lancet Oncology Key Points and Investor Highlights Full results of the CHOPIN Phase 2...

   Ad